Sarepta Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | Outperform |
2
|
$28.88 | Buy/Sell | $32.87 | 5.61% | 6 | $162.57B |
| SAN | Sanofi | Outperform |
16
|
89.52€ | Buy/Sell | 102.80€ | 21.76% | 9 | 112.71€B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.44k | Buy/Sell | ¥5.24k | 12.05% | 0 | ¥10.31T |
| MRNA | Moderna | Outperform |
16
|
$166.61 | Buy/Sell | $135.42 | -24.37% | 1 | $62.86B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 8.85% | 0 | ¥6.49T |
| BIIB | Biogen | Outperform |
10
|
$217.81 | Buy/Sell | $299.62 | 32.45% | 13 | $31.75B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$147.76 | Buy/Sell | $245.24 | 47.20% | 7 | $18.90B |
| BAX | Baxter International Inc | Hold |
17
|
$33.90 | Buy/Sell | $44.86 | 29.79% | 5 | $17.33B |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$75.52 | Buy/Sell | $111.56 | 46.32% | 5 | $14.62B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$37.28 | Buy/Sell | $55.60 | 60.94% | 3 | $5.76B |
| DYN | Dyne Therapeutics | Buy |
5
|
$31.22 | Buy/Sell | $28.13 | 44.14% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | Hold |
6
|
$25.51 | Buy/Sell | $23.40 | 1.92% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥3.52k | Buy/Sell | ¥8.34k | 44.97% | 0 | ¥261.33B |
| WVE | Wave Life Sciences | Outperform |
6
|
$6.22 | Buy/Sell | $9.21 | 92.93% | 3 | $688.23M |
| STOK | Stoke Therapeutics | Buy |
4
|
$14.41 | Buy/Sell | $19.33 | 38.79% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$3.29 | Buy/Sell | $6.34 | 66.57% | 0 | $535.96M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.21 | Buy/Sell | $10.21 | 108.04% | 7 | $456.83M |
| PYC | PYC Therapeutics | Buy |
8
|
$0.12 | Buy/Sell | $0.30 | 183.33% | 1 | $294.90M |
| AIM | AIM ImmunoTech | Buy |
0
|
$0.39 | Buy/Sell | $3.83 | 797.44% | 0 | $21.15M |